WbpA, WbpB, WbpE, WbpD, and WbpI has been proposed for the production of this sugar in P. aeruginosa, based on analysis of genes present in the B-band LPS biosynthesis cluster. In the analogous B. pertussis cluster, homologs of wbpB to wbpI were present, but a putative dehydrogenase gene was missing; therefore, the biosynthetic mechanism for UDP-D-ManNAc3NAcA was unclear. Nonpolar knockout mutants of each P. aeruginosa gene were constructed. Complementation analysis of the mutants demonstrated that B-band LPS production was restored to P. aeruginosa knockout mutants when the relevant B. pertussis genes were supplied in trans. Thus, the genes that encode the putative oxidase, transaminase, N-acetyltransferase, and epimerase enzymes in B. pertussis are functional homologs of those in P. aeruginosa. Two candidate dehydrogenase genes were located by searching the B. pertussis genome; these have 80% identity to P. aeruginosa wbpO (serotype O6) and 32% identity to wbpA (serotype O5). These genes, wbpO 1629 and wbpO 3150 , were shown to complement a wbpA knockout of P. aeruginosa. Capillary electrophoresis was used to characterize the enzymatic activities of purified WbpO 1629 and WbpO 3150 , and mass spectrometry analysis confirmed that the two enzymes are dehydrogenases capable of converting UDP-D-GlcNAc, UDP-D-GalNAc, to a lesser extent, and UDP-D-Glc, to a much lesser extent. Together, these results suggest that B. pertussis produces UDP-D-ManNAc3NAcA through the same pathway proposed for P. aeruginosa, despite differences in the genomic context of the genes involved. Nomenclature for the conceptual division of LPS differs between different organisms. In Bordetella pertussis, an obligate human pathogen and the causative agent of whooping cough, the core oligosaccharide is linked to a structure called the band A trisaccharide. The band A trisaccharide from B. pertussis 1414 is composed of N-acetyl-D-glucosamine (D-GlcNAc), 2,3-diacetamido-2,3-dideoxy-D-mannuronic acid (D-ManNAc3NAcA), and 2-acetamido-4-methylaminofucose (FucNAc4NMe) (6). The related species Bordetella bronchiseptica, a pathogen of animals, and Bordetella parapertussis, a pathogen of both humans and animals, also have D-ManNAc3NAcA present in the LPS (33). B. bronchiseptica and B. parapertussis LPS also contains a repeating polysaccharide known as the O antigen (12). The O antigen contains 2,3-diacetamido-2,3-dideoxy-L-galactosamine (L-GalNAc3NAcA) (33), which is thought to be synthesized from UDP-D-ManNAc3NAcA by the enzymes of the wbm gene cluster (21). In B. pertussis, the LPS is not capped with the O antigen due to the deletion of the wbm cluster (33).
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It is intriguing that the rare di-N-acetylated mannuronic acid sugar residue D-ManNAc3NAcA is present in both P. aeruginosa serogroup O2 and in the LPS of B. pertussis. LPS is an important virulence factor of both P. aeruginosa and B. pertussis: in P. aeruginosa, the O antigen has been shown to be involved in protection from phagocytosis (13) and serum-mediated killing (11) , and it also plays a role in eliciting a high level of immune response in the host (9) . In addition, mutants of P. aeruginosa that lack the O antigen have a 50% lethal dose that is 1,000-fold higher than that of the wild-type organism in an animal model (9) . In B. pertussis, the band A trisaccharide prevents clearance of the organism by host surfactant protein A (38) and confers protection to the bacterium from complement-mediated cell lysis (18) . Mutant strains of B. pertussis that lack the band A trisaccharide were shown to be defective in colonization of the mouse trachea and nasal cavity (18) . Mutants of B. bronchiseptica lacking wild-type LPS showed reduced resistance to oxidative stress and antimicrobial peptides (2, 44) .
The biosynthesis of UDP-D-ManNAc3NAcA in P. aeruginosa has been studied by use of genetic and biochemical techniques. A five-step biosynthesis pathway involving the sequential catalytic activities of WbpA, WbpB, WbpE, WbpD, and WbpI has been proposed ( Fig. 1) . Genetic evidence has already been given that the initial enzyme and the last enzymes (encoded by wbpA, wbpD, and wbpI) are essential for B-band O antigen biosynthesis (5, 43) . The initial enzyme of the pathway, WbpA, is a 6-dehydrogenase that converts UDP-D-GlcNAc to UDP-N-acetylglucosaminuronic acid (UDP-D-GlcNAcA) (31) . Another 6-dehydrogenase, WbpO of P. aeruginosa serotype O6, has 53% similarity to WbpA and has been shown to convert UDP-D-GalNAc to UDP-D-GalNAcA for use in the O antigen but is also capable of converting UDP-D-GlcNAc to UDP-DGlcNAcA (30, 48) . In P. aeruginosa PAK (serotype O6), the WbpO enzyme is required for both O antigen biosynthesis and flagellin glycosylation (30) . The B-band O antigen biosynthesis cluster of P. aeruginosa serotype O6 contains wbpO followed by wbpP (3) , which encodes a 4-epimerase that can catalyze the reversible conversion of UDP-D-GlcNAc to UDP-D-GalNAc or UDP-D-GlcNAcA to UDP-D-GalNAcA (8, 30) . Despite both enzymes being bifunctional, data from kinetic analysis of WbpO and equilibrium analysis of WbpP suggested a preference in vivo for WbpO to work first, converting UDP-D-GlcNAc to UDP-DGlcNAcA, followed by WbpP, converting UDP-D-GlcNAcA to UDP-D-GalNAcA (30) . Thus, homologs of either WbpA or WbpO are theoretically capable of providing the required 6-dehydrogenation of UDP-D-GlcNAc to initiate the UDP-D-ManNAc3NAcA biosynthesis pathway.
The intermediate three steps in the UDP-D-ManNAc3NA cA biosynthesis pathway have been proposed, but functional evidence for the role of the enzymes has yet to be provided. UDP-D-GlcNAcA is thought to be used in an oxidation reaction catalyzed by WbpB, forming UDP-2-acetamido-2-deoxy-D-ribo-hex-3-uluronic acid (UDP-3-keto-D-GlcNAcA), which in turn is the substrate for transamination by WbpE, yielding UDP-2-acetamido-3-amino-2,3-dideoxy-D-glucuronic acid (UDP-D-GlcNAc3NA). This residue is thought to be the substrate for WbpD, a putative N-acetyltransferase, which synthesizes UDP-2,3-diacetamido-2,3-dideoxy-D-glucuronic acid (UDP-D-GlcNAc3 NAcA), utilizing acetyl-coenzyme A as a cofactor (43) . WbpI is the final enzyme in the pathway and is a known to be a UDP-DGlcNAc3NAcA 2-epimerase that produces UDP-D-ManNAc3 NAcA for incorporation into B-band LPS (46) . Each of the required enzymes is encoded in the B-band O-antigen biosynthesis cluster (37) .
The analogous band A trisaccharide biosynthesis cluster in B. pertussis contains 12 genes, which include homologs of the second to fifth genes encoding enzymes involved in UDP-DManNAc3NAcA synthesis in P. aeruginosa (Fig. 2) . The missing gene in this cluster is an open reading frame (ORF) encoding a putative UDP-D-GlcNAc 6-dehydrogenase, required for the first step in the pathway. Thus, it was unclear whether synthesis of UDP-D-ManNAc3NAcA in B. pertussis could follow the same pathway as that in P. aeruginosa. Further analysis of the B. pertussis genome sequence led to the identification of two putative dehydrogenases, WbpO 1629 and WbpO 3150 , which were named based on the existing annotation and genomic positions. In this study, we used genetic and biochemical ap- This report documents the complementation of knockout mutants of wbpA (encoding a 6-dehydrogenase), wbpB (encoding a putative oxidase), wbpE (encoding a putative transaminase), wbpD (encoding a putative N-acetyltransferase), and wbpI (encoding a 2-epimerase) derived from P. aeruginosa PAO1 with wbpO 1629 and wbpO 3150 , wlbA, wlbC, wlbB, and wlbD, respectively, of B. pertussis BP536. Each gene was able to restore B-band LPS production to the respective knockout mutant, indicating that each pair has the same function in vivo. The B. pertussis enzymes WbpO 1629 and WbpO 3150 have not been studied previously, so both were overexpressed and purified for use in reactions with a panel of possible substrates. Both WbpO 1629 and WbpO 3150 were shown to be 6-dehydrogenases that utilize UDP-D-GlcNAc and UDP-D-GalNAc, like the 6-dehydrogenase of P. aeruginosa serotype O6 (WbpO), but the enzymes of B. pertussis were shown to also have a novel ability to use UDP-D-Glc. Collectively, these results suggest that B. pertussis produces UDP-D-ManNAc3NAcA through the same biochemical pathway proposed for P. aeruginosa, despite differences in the genomic context of the genes involved.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The bacterial strains and plasmids used in this study are listed in Table 1 . Bacterial strains were routinely propagated at 37°C in Luria-Bertani (LB) broth (Invitrogen Canada Inc., Burlington, Ontario, Canada). Pseudomonas isolation agar (Difco Becton, Sparks, MD) was used for selecting transconjugants from the mating experiments. The antibiotics in the selection media were used at the following concentrations for Escherichia coli strains: ampicillin, 100 g/ml; kanamycin, 50 g/ml; chloramphenicol, 34 g/ml; gentamicin (Gm), 15 g/ml; and tetracycline, 15 g/ml. For P. aeruginosa strains, the following antibiotics were used: carbenicillin, 500 g/ml; Gm, 300 g/ml; and tetracycline, 60 g/ml. Isopropyl-␤-D-thiogalactopyranoside (IPTG) was used at 0.4 mM for expression studies. Antibiotics and IPTG were obtained from Sigma-Aldrich (Oakville, Ontario, Canada).
General DNA methods. Oligonucleotide primers were prepared by the Laboratory Services Division of the University of Guelph (Guelph, Ontario, Canada) or by Sigma-Genosys Canada (Oakville, Ontario, Canada). Sequences of all primers used and a listing of PCR cycling conditions are available on request. Restriction enzymes and T4 DNA ligase were from Invitrogen (Burlington, Ontario, Canada), except for XbaI from New England Biolabs (Pickering, Ontario, Canada). All enzymes were used according to the manufacturers' instructions. After ligation, plasmids were transformed into E. coli JM109 or DH5␣ by chemical transformation. For complementation, plasmid DNA was introduced into P. aeruginosa by chemical transformation according to the benchtop method (7) . All constructs were verified by restriction digestion and/or nucleotide sequencing at the Laboratory Services Division of the University of Guelph.
Generation of nonpolar knockout mutants. Null mutants of wbpA, wbpD, and wbpI in the P. aeruginosa PAO1 background were previously constructed by our group (5, 43) . Knockout mutants of wbpB and wbpE were constructed using the allelic replacement method described by Schweizer and Hoang (40) . Briefly, knockout constructs of wbpB and wbpE were generated by insertional mutagenesis with a Gm resistance cassette. For the wbpB knockout, the gene was amplified from P. aeruginosa PAO1 genomic DNA, using primers that incorporate a BamHI site and an EcoRI site, and the resultant product was ligated into pET-28a (Novagen, Mississauga, Ontario, Canada). The wbpB gene was disrupted by insertion of the Gm r cassette from PstI-digested pPS856 into the two internal PstI sites. The wbpB::Gm region was PCR amplified using KOD polymerase according to the manufacturer's directions (Novagen), using primers that introduced HindIII sites at each end. After PCR, the product was purified using a HighPure PCR purification kit (Roche) and digested with HindIII. The HindIIIdigested wbpB::Gm construct was ligated into HindIII-digested pEX18Ap (20) . Clones were confirmed by restriction digestion and then transformed into E. coli SM10 for introduction into P. aeruginosa PAO1 by conjugal transfer. Conjugal transfer and phenotypic selection were carried out according to the methods described by Wenzel et al. (43) . For the wbpE knockout, wbpE was first cloned into an expression vector and then subcloned into a suicide vector for use in knockout construction. The wbpE gene from P. aeruginosa PAO1 was amplified from genomic DNA by PCR, using Pwo polymerase according to the method supplied by the manufacturer (Roche Diagnostics, Laval, Quebec, Canada). Both the wbpE PCR product and pET-23dr were digested with NcoI and BamHI and ligated overnight at 15°C, using T4 DNA ligase (NEB). The resulting expression construct, pWMJL085, was used as a template for a PCR using primers BADE5 and BADE3. The PCR product was then ligated into pBAD24 via XbaI and SphI sites. The Gm r cassette from pUCGm was removed via SmaI and blunt end ligated into the MscI site of wbpE, generating pBAD24-wbpE::Gm. The disrupted wbpE::Gm construct was excised through digestion by XbaI and HindIII and ligated to XbaI/HindIII-digested pEX18Ap. The final construct, pEX18Ap-wbpE::Gm, was introduced into P. aeruginosa PAO1 by conjugal transfer and selection as previously described for the wbpB knockout. Successful knockouts of each gene were confirmed by a Gm r Cb s phenotype, correct PCR fragment size, silver staining of LPS, and Western blotting with the anti-B-band monoclonal antibody (MAb) MF15-4.
Assignment of B. pertussis gene functions. The amino acid sequences of the five enzymes of P. aeruginosa proposed to be involved in UDP-D-ManNAc3NAcA biosynthesis were used to query the Sanger database of predicted B. pertussis proteins. The top-scoring hits were considered in combination with the locations of the genes, with preference given to those in the band A trisaccharide biosynthesis cluster. Assignment of homologous pairs of enzymes from P. aeruginosa and B. pertussis, using the NCBI BLAST 2 Sequences tool (http://blast.ncbi.nlm .nih.gov/bl2seq/wblast2.cgi), formed the hypotheses to be tested by cross-complementation analysis. Homologs of all genes selected for analysis from B. pertussis are also present in B. bronchiseptica and B. parapertussis.
Construction of complementation vectors. The complementation vectors used were pUCP26 and pUCP27, which differ only in the orientation of the multiple cloning site. If available, the P. aeruginosa genes were subcloned from existing pET-28a or pET-23dr expression constructs.
(i) Dehydrogenases. Plasmid pCQW14 (31) was used to subclone His 6 -WbpA via XbaI-XhoI ligated to XbaI-SalI of pUCP27 to create p27-His 6 -WbpA. The WbpA gene homologs from B. pertussis, wbpO 3150 and wbpO 1629 , were amplified from a boiled lysate of B. pertussis BP536 by use of KOD polymerase according to the manufacturer's directions (Novagen). wbpO PCR products purified by gel excision were digested and ligated via NdeI-EcoRI into pET-28a to yield the expression constructs. 28a-His 6 -WbpO 3150 was then digested with XbaI and EcoRI to liberate the His 6 -WbpO 3150 fragment, which was ligated into XbaIEcoRI-digested pUCP27. 28a-His 6 -WbpO 1629 was digested with XbaI and HindIII to liberate the His 6 -WbpO 1629 fragment, which was ligated into XbaIHindIII-digested pUCP26.
(ii) Oxidases. The wbpB gene was PCR amplified from PAO1 chromosomal DNA by using primers that incorporated BamHI and EcoRI restriction sites, using Pwo polymerase according to the manufacturer's instructions (Invitrogen). The wbpB PCR product was cleaned and ligated into pET-28a via BamHI-EcoRI sites to yield pET-His 6 -WbpB, an expression vector for His 6 (32, 42) . (A) B-band O antigen gene cluster from P. aeruginosa PAO1 (serotype O5). (B) Band A trisaccharide gene cluster from B. pertussis Tohama I, also known as the wlb locus. Initial proposed functions for the genes in these clusters were provided from sequence and mutational analysis of P. aeruginosa and B. pertussis, respectively (4, 35) . Genes known or predicted to be involved in the biosynthesis of UDP-D-ManNAc3NAcA are shaded gray; genes known or predicted to encode dehydrogenases are shaded gray with black hatching.
mentation, pET-His 6 -WbpB was digested with XbaI and HindIII, and the liberated fragment was ligated into pUCP27. A C-terminally polyhistidine-tagged construct was also generated by amplification of wbpB without a stop codon from chromosomal DNA, using KOD polymerase according to the manufacturer's directions (Novagen). The PCR product was then TOPO cloned with a pCRBlunt-II-TOPO kit (Invitrogen) according to the manufacturer's protocol. wbpB was then subcloned via NcoI and XhoI sites in the primers and ligated into pET-28a, generating pET-WbpB-His 6 . For the complementation construct, PCR was performed on pET-WbpB-His 6 , with XbaI and HindIII sites in the primers. KOD polymerase was used according to the manufacturer's directions (Novagen). The digested PCR product was ligated to XbaI-SalI-digested pUCP27. The WbpB gene homolog from B. pertussis, wlbA, was amplified from the cosmid BbLPS1, which contains the band A trisaccharide biosynthesis cluster from B. bronchiseptica (32, 33) . Use of BbLPS1 allowed chromosomal PCR problems to be resolved, and the sequence of wlbA from B. pertussis was identical to that from B. bronchiseptica. KOD polymerase was used according to the manufacturer's directions (Novagen), and after PCR, the wlbA band was purified by gel excision, using a HighPure PCR purification kit (Roche). The purified wlbA PCR product was digested using the EcoRI and BamHI restriction sites on the primers and then ligated into pUCP26. Clones were confirmed by DNA sequencing.
(iii) Transaminases. pWMJL085 was digested with XbaI and BamHI to liberate the His 6 -WbpE insert; this was then ligated into pUCP26. The WbpE gene homolog from B. pertussis, wlbC, was amplified from a boiled lysate of B. pertussis BP536 by use of KOD polymerase according to the manufacturer's directions (Novagen). After PCR, the wlbC band was purified by gel excision, and the purified wlbC PCR product was ligated into pUCP27 via BamHI and EcoRI sites.
(iv) N-Acetyltransferases. pCQW13, which encodes His 6 -WbpD in pUCP26, has been described previously (43) . The homologous gene wlbB was amplified from a boiled lysate of B. pertussis BP536 by use of KOD polymerase according to the manufacturer's directions (Novagen). Using the EcoRI and BamHI restriction sites on the primers, wlbB was digested and ligated into pUCP26.
(v) Epimerases. p26-His 6 -WbpI and p26-His 6 -WlbD were subcloned from previously described expression constructs in pET-23dr (46) . The affinity-tagged genes were liberated, ligated to pUCP26 via XbaI and BamHI sites, and verified by restriction digestion. (19) . LPS was separated by using 12.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (25) or 4 to 12% Bis-Tris NuPage gels (Invitrogen) and was visualized by an ultrafast silver staining method (14) . Western immunoblotting was performed according to a standard procedure used in our laboratory, and the blots were probed using MAb MF15-4, specific for B-band O antigen (26) . The secondary antibody was alkaline phosphatase-conjugated goat anti-mouse immunoglobulin G (Jackson Immunoresearch). Blots were developed according to standard protocols for colorimetric detection (Qiagen, Mississauga, Ontario, Canada).
Protein expression and purification. Expression clones were transformed into E. coli BL21(DE3) and induced using 1 mM IPTG for 3 h at 37°C. Cultures (250 ml) were harvested by centrifugation at 5,000 ϫ g for 10 min in an Avanti J25I centrifuge (Beckman Coulter Canada, Mississauga, Ontario, Canada), and purification was carried out according to the protocol established for His 6 -WbpA (31) . Proteins separated by SDS-PAGE were visualized by staining with Coomassie brilliant blue R-250 (Sigma-Aldrich). Proteins were quantitated by spectrophotometric assay, using the formula A 280 ϭ εCl, where ε is 37,820 M Ϫ1 cm Ϫ1 , as predicted by ProtParam software (15) , and Cl is molar concentration and path length (in cm).
Dehydrogenase reactions and CE analyses. Dehydrogenase reactions were similar to those used for His 6 -WbpA (31), with mixtures consisting of 2.5 mM NAD ϩ , 100 mM Tris-HCl buffer, pH 7.5, 100 mM ammonium sulfate, 1 mM substrate, and 10.5 g of enzyme in a 35-l volume. UDP-D-GlcNAc, UDP-DGalNAc, UDP-D-Glc, and UDP-D-Gal were obtained from Sigma-Aldrich and tested individually as potential substrates. TDP-D-Glc was produced from TTP and glucose-1-phosphate through reaction with RmlA and RmlB and then verified by mass spectrometry (MS) analysis (unpublished data). Reactions were allowed to proceed for 4 h at 37°C and were then stopped by freezing at Ϫ20°C until capillary electrophoresis (CE) analysis. For CE analysis, 35 l of water was added to each reaction mix, and the samples were centrifuged for 5 min at 12,000 ϫ g at room temperature before 60-l aliquots were loaded into a P/ACE MDQ glycoprotein system (Beckman Coulter). The capillary was bare silica (75 m by 60 cm, with a detector at 50 cm), and the running buffer was 25 mM sodium tetraborate, pH 9.5. The capillary was conditioned at the start of each run with 1 M sodium hydroxide for 2 min, followed by running buffer for 2 min. Samples were introduced by pressure injection for 16 s, and separation was performed at 22 kV. Detection was done by measuring UV absorbance, monitored at 254 nm. Electropherograms were analyzed using Beckman 32 Karat software and SigmaPlot. Reactions were performed in triplicate, and results were averaged to calculate the percent conversion for each enzyme with each substrate. For comparison to theoretical reaction products, known standards were obtained from Sigma-Aldrich (UDP-D-GlcA) or through enzymatic synthesis using His 6 -WbpA or His 6 -WbpO according to established methods (UDP-D-GlcNAcA and UDP-D-GalNAcA) (30) .
MS. For MS, unpurified dehydrogenase reaction mixtures were mixed directly with matrix solution (2 mg of 3,4-dihydroxybenzoic acid in 20% ethanol) at an analyte-to-matrix ratio of 1:2 (vol/vol), and 1 l was spotted on the matrixassisted laser desorption ionization (MALDI) sample target and allowed to dry at room temperature. In some cases, good crystal formation was not achieved and the spots on the MALDI plate looked shiny; in these cases, the sample spots were covered by an additional 1 l of matrix solution. After the samples were dried at room temperature, crystals were forming on the edges of the sample spots. Proteins were present in the reaction mixtures with UDP-D-Glc and UDP-D-GlcNAc but were removed by filtration using a Microcon YM-10 centrifugal filter device (Millipore Corporation, Bedford, MA) for the UDP-D-GalNAc sample. Analysis of the total reaction mixtures was performed using a MALDItime-of-flight MS instrument (model Reflex III; Bruker, Germany) equipped with a 337-nm nitrogen laser (Biological Mass Spectrometry Facility, University of Guelph). Samples were analyzed in reflectron and negative-ion modes, scanning from 0 to 1,000 m/z and using ion suppression of up to 150 m/z. For all experiments, ion sources 1 and 2 were held at 20 kV and 16.35 kV, respectively, and guiding lens voltage was held at 9.75 kV. The reflector detection gain was set up at 5.3, with pulsed ion extraction at 200 ns. The nitrogen laser power was set to the minimum level necessary to generate a reasonable signal and to avoid possible degradation of analytes. Typically, 15 to 25% of laser energy was used. Two-point external calibration was performed, using the [ 
RESULTS
Functional prediction of B. pertussis genes required for UDP-D-ManNAc3NAcA biosynthesis. Based on the similarities of the predicted amino acid sequences to those of P. aeruginosa sequences, six ORFs were assigned putative functions. The wlb locus, known to be involved in band A trisaccharide biosynthesis in Bordetella (1), encodes the putative oxidase (wlbA), N-acetyltransferase (wlbB), and transaminase (wlbC) as well as the previously characterized UDP-D-GlcNAc3NAcA 2-epimerase (wlbD) (46) . WlbA has 40% similarity to WbpB of P. aeruginosa, WlbB shares 85% similarity with WbpD, WlbC has 74% similarity to WbpE, and WlbD shares 70% similarity with WbpI. ORFs encoding proteins with similarity to WbpO and WbpA dehydrogenases from P. aeruginosa were not found inside the band A trisaccharide biosynthesis cluster but, rather, elsewhere in the chromosome (Fig. 2) . Two ORFs, BP1629 and BP3150, were found in separate loci that may be involved in polysaccharide biosynthesis; BP1629 is in a putative capsule locus, while BP3150 is part of a cryptic locus. Both ORFs are adjacent to genes encoding putative homologs of WbpP, the 4-epimerase that works with the WbpO dehydrogenase in P. aeruginosa serotype O6. BP1630 and BP3149, the putative wbpP genes from B. pertussis, encode proteins that are 100% identical to each other and 80% similar to WbpP of P. aeruginosa serotype O6. The putative dehydrogenases, BP1629 and BP3150, share 90% similarity to WbpO of P. aeruginosa (WbpO O6 ) and 54% similarity to WbpA, contain conserved domains of UDP-glucose/GDP-mannose dehydrogenase families, and are 99% identical to each other. For convenience, the genes were therefore called wbpO 1629 and wbpO 3150 . The sequence differences between WbpO 1629 and WbpO 3150 are restricted to the N terminus of the proteins: WbpO 1629 has five additional amino acids relative to WbpO 3150 , but after the initial 63 bp, the remaining sequences were identical even at the DNA level. Although the predicted Rossmann fold for predicted NAD(P) binding is close to the N terminus, the GXGXXG motif is located at amino acids 17 to 23 of WbpO 1629 and 12 to 17 of WbpO 3150 , so the differences between the two proteins do not seem to affect any structural features. Both WbpO 1629 and WbpO 3150 were targeted for further characterization to demonstrate that they are dehydrogenases and to investigate if their functional properties are more like those of WbpO of P. aeruginosa serotype O6 or WbpA of P. aeruginosa serotype O5.
Complementation of P. aeruginosa knockout constructs with corresponding wild-type genes. Knockouts of wbpB and wbpE were transformed with plasmids encoding His 6 -WbpB, WbpBHis 6 , or His 6 -WbpE. B-band O antigen was detected in each strain after transformation, but the empty vector alone could not restore B-band production (data not shown). A wbpA knockout strain was previously complemented by wbpA (5) and was complemented here with plasmid-encoded His 6 -WbpA (Fig. 3) . Complementation of wbpD and wbpI knockouts with wbpD and wbpI was also previously reported (5, 43, 46) , and these strains can also be complemented with N-terminally histidine-tagged fusions (data not shown).
Cross-complementation of putative B. pertussis UDP-D-GlcNAc dehydrogenases. SDS-PAGE was used to separate the LPS and was allowed to run for an extended period to improve the resolution of the B-band O antigen bands. The control P. aeruginosa PAO1 LPS revealed a ladder-like banding pattern that is known to represent individual LPS species with different numbers of O antigen repeats (Fig. 3) . Because of the extended running time for SDS-PAGE, the LPS core bands are not visible on the gel. The wbpA knockout of P. aeruginosa PAO1 is devoid of B-band O antigen but still produces A-band O antigen in a variety of lengths. A-band O antigen bands were present on the silver-stained SDS-PAGE gel but were not reactive with the B-band-specific MAb MF15-4 in a Western blot (Fig. 3) . B-band O antigen was restored when His 6 -WbpA was expressed in trans, as tested by LPS silver staining and Western blotting with MAb MF15-4 (Fig. 3) . No differences were detected in the modality of the A-band or B-band O antigens. The hexahistidine tag did not interfere with the in vivo function of His 6 -WbpO 1629 or His 6 -WbpO 3150 , since the plasmid-carried His-tagged genes were capable of restoring B-band O antigen production in the wbpA mutant (Fig. 3) . As expected, the empty vector control was not able to complement the B-band O antigen deficiency in the wbpA mutant (Fig. 3) .
Cross-complementation of B. pertussis band A biosynthesis cluster members. Silver-stained SDS-PAGE analysis of wildtype PAO1 LPS showed two dark bands of low molecular weight (Fig. 4) . These are known as the core and core-plus-one O-antigen repeat unit, based on previous findings of Western blotting with anti-core and anti-core-plus-one MAbs (data not shown). In addition, a range of high-molecular-weight molecules are present, which are the LPS bands containing A-or B-band O antigen polymers. Knockouts of the P. aeruginosa PAO1 genes wbpB, wbpE, wbpD, and wbpI were expected to abrogate the functions of the oxidase, transaminase, N-acetyltransferase, and epimerase, respectively. In comparison to strain PAO1, each individual knockout construct lacked Bband O antigen, as determined by the lack of reactivity to MAb MF15-4 (B band specific) in the Western immunoblot (Fig. 4) . In addition, the core-plus-one O antigen band was absent in the LPS of each of the knockout strains (Fig. 4) . As expected, an empty vector control did not alter the LPS profile (Fig. 4) . When copies of the putative oxidase gene (wlbA), putative transaminase gene (wlbC), putative N-acetyltransferase gene (wlbB), and established 2-epimerase gene (wlbD) from B. pertussis were individually provided on plasmids to P. aeruginosa oxidase (wbpB), transaminase (wbpE), N-acetyltransferase (wbpD), and epimerase (wbpI) knockout strains, respectively, the production of B-band O antigen was restored (Fig. 4) . Purification of recombinant dehydrogenases. Milligram quantities of His 6 -WbpO 1629 and His 6 -WbpO 3150 were obtained after affinity chromatography and buffer exchange, at Ͼ98% purity, as judged by SDS-PAGE and densitometry analysis (Fig. 5) . His 6 -WbpO 1629 and His 6 -WbpO 3150 are predicted to have molecular weights of 49,388 and 49,007, respectively, and the apparent molecular weights are in agreement with these estimates (Fig. 5) .
CE of dehydrogenase-substrate reactions. Control reaction mixtures lacking enzyme resolved three peaks in each case; the two peaks which were consistent among all traces were identified as NAD ϩ and a minor contaminant present with NAD ϩ , while the third peak was identified as the sugar-nucleotide substrate based on the use of reagent standards (Fig. 6 ). Reaction mixtures containing WbpO 1629 or WbpO 3150 and UDP-D-Glc, UDP-D-GlcNAc, or UDP-D-GalNAc showed two new large peaks that were not present in the controls. One of these peaks was found for the reactions with all of the substrates and was identified as NADH ( 
DISCUSSION
In P. aeruginosa, five genes are predicted to be required for the production of UDP-D-ManNAc3NAcA, including wbpA, wbpB, wbpE, wbpD, and wbpI. The evidence presented here demonstrates that B-band O antigen is not produced when wbpB or wbpE is knocked out in P. aeruginosa (Fig. 4) , consistent with a deficiency in UDP-D-ManNAc3NAcA synthesis. Thus, together with prior studies, genetic evidence has been obtained to show that all five members of the proposed pathway are essential for the production of UDP-D-ManNAc3 NAcA in P. aeruginosa PAO1. Complementation of wbpB and wbpE knockouts with His-tagged versions of the wbpB and wbpE gene products have established that His 6 -WbpB and His 6 -WbpE are functional (data not shown) and can be used for further biochemical studies.
By constructing a complete set of knockouts in the genes that encode enzymes for the UDP-D-ManNAc3NAcA biosynthetic pathway, we made a unique set of tools whereby the function of the corresponding homologs from B. pertussis could be tested through pairwise cross-complementation. Initial assignments of B. pertussis genes to particular pathway steps, which was based on alignment comparison of the gene products with those encoded by the wbp cluster of P. aeruginosa PAO1, were supported by the ability of each B. pertussis gene to cross-complement the relevant wbp knockout (Fig. 3 and 4) . This genetic evidence suggests that wbpO 1629 The presence of functional homologs encoding putative UDP-D-ManNAc3NAcA biosynthesis enzymes in P. aeruginosa and B. pertussis (Fig. 2) raises questions about the evolutionary conservation of the proposed pathway. P. aeruginosa and B. pertussis are members of the Proteobacteria, belonging to the Gammaproteobacteria and Betaproteobacteria, respectively. Homologs of each of these five genes can also be identified in several other proteobacteria, including Marinomonas sp. (Gammaproteobacteria), Polaromonas naphthalenivorans (Betaproteobacteria), and Wolinella succinogenes (Epsilonproteobacteria). A subgroup contains homologs to wbpABED but not wbpI (which encodes a UDP-D-GlcNAc3NAcA 2-epimerase), suggesting that UDP-D-GlcNAc3NAcA may be produced; these include Roseovarius nubinhibens (Alphaproteobacteria) and Ralstonia eutropha (Betaproteobacteria). In many cases, the genes homologous to those of the UDP-D-ManNAc3NAcA biosynthesis cluster from P. aeruginosa PAO1 are also found in clusters. Unfortunately, little is known about the composition of the LPS in these gram-negative bacteria at this time, although evidence has been given for the presence of mannosederived residues in the O antigens of W. succinogenes and Wolinella recta (16, 24) . Interestingly, evidence has been given for the presence of ManNAc3NAcA in the gram-positive bacterium Geobacillus stearothermophilus (29, 39) , which belongs to the Firmicutes. Sequencing of Geobacillus stearothermophilus is in progress at the University of Oklahoma, and the use of tBLASTn searches (http://www.genome.ou.edu/blast/bstearo _blastall.html) indicates that homologs of all five UDP-D-Man NAc3NAcA genes are present [B. Roe, S. Lewis, B. Perry, F. Najar, and R. Morales-Diaz, Bacillus (Geobacillus) stearothermophilus genome sequencing project]. Although further work is required, we suggest that the proposed pathway for UDP-DManNAc3NAcA biosynthesis may be highly conserved among this broad range of bacteria. In future studies, the findings of this study can be exploited to predict the functions of the genes required for UDP-D-ManNAc3NAcA biosynthesis in organisms known to produce ManNAc3NAcA. CE analysis showed that WbpO 1629 and WbpO 3150 are promiscuous 6-dehydrogenases, capable of utilizing UDP-D-GlcNAc, UDP-D-GalNAc, and UDP-D-Glc as substrates, but not TDP-DGlc or UDP-D-Gal (Fig. 3 and Table 2 ). MS analysis of reactions confirmed the production of UDP-D-GlcNAcA, UDP-D-GalNAcA, and UDP-D-GlcA by use of His 6 -WbpO 3150 , but MS was not used to analyze His 6 -WbpO 1629 reactions, since CE had demonstrated the products of both dehydrogenases to be identical. The two WbpO enzymes from Bordetella have higher similarity at the amino acid level to the UDP-D-GlcNAc/UDP-D-GalNAc 6-dehydrogenase WbpO of P. aeruginosa serotype O6 than to the UDP-D-GlcNAc 6-dehydrogenase WbpA of P. aeruginosa serotype O5; the ability of the B. pertussis enzymes to use both UDP-D-GlcNAc and UDP-D-GalNAc further supports the annotation with the gene name wbpO. WbpA acts as the first enzyme in the UDP-D-ManNAc3NAcA pathway that we have presented, and it is clear that the B. pertussis WbpO enzymes can provide the same activity, since they complement the 
